Your browser doesn't support javascript.
loading
The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms.
Jones, Amy V; Campbell, Peter J; Beer, Philip A; Schnittger, Susanne; Vannucchi, Alessandro M; Zoi, Katerina; Percy, Melanie J; McMullin, Mary Frances; Scott, Linda M; Tapper, William; Silver, Richard T; Oscier, David; Harrison, Claire N; Grallert, Harald; Kisialiou, Aliaksei; Strike, Paul; Chase, Andrew J; Green, Anthony R; Cross, Nicholas C P.
Affiliation
  • Jones AV; Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, United Kingdom.
Blood ; 115(22): 4517-23, 2010 Jun 03.
Article in En | MEDLINE | ID: mdl-20304805
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Janus Kinase 2 / Receptors, Thrombopoietin / Mutation / Myeloproliferative Disorders Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2010 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Janus Kinase 2 / Receptors, Thrombopoietin / Mutation / Myeloproliferative Disorders Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2010 Type: Article Affiliation country: United kingdom